Latest Market Data
Hang Seng Index
23,345.05
-108.11 (-0.46%)
HSCEI
8,468.29
-41.38 (-0.49%)
Hang Seng TECH Index
5,281.34
-16.50 (-0.31%)
Hang Seng HKEX Stock Connect China Enterprises Index
3,916.00
-38.53 (-0.97%)
MSCI China A 50 Connect Index
2,133.24
-13.44 (-0.63%)
HSI Volatility Index
23.66
-0.90 (-3.66%)
CSI 300 Index
3,889.09
-18.11 (-0.46%)
CES China120 Index
6,526.32
-64.20 (-0.97%)
USD/CNH Spot
7.2077
-0.0006 (-0.01%)
USD/INR Spot
85.4900
-0.0280 (-0.03%)
HKEX Bitcoin Reference Index
105,512.39
+1,565.6 (+1.51%)
HKEX Ether Reference Index
2,568.24
+58.06 (+2.31%)
CNH Gold Futures – Spot Price Index
-
- (-)
USD Gold Futures – Spot Price Index
-
- (-)
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

CHINA RESOURCES PHARMACEUTICAL GROUP LTD. (3320)

CHINARES PHARMA (3320)

HK$4.950

0.000 (0.00%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$4.950
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$4.940
TURNOVER
HK$30.64M
VOLUME
6.20M
MKT CAP
HK$31.09B
LOT SIZE
500
BID
HK$4.940
ASK
HK$4.950
EPS
RMB0.53
P/E
8.82x
DIV YIELD
2.97%
INTRA-DAY 52W
High HK$4.970 HK$7.110
Low HK$4.910 HK$4.610
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 16 May 2025 16:08 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.00300K600K10:0011:0012:0013:0014:0015:0016:004.8404.8804.9204.9605.000Prev. Close
4.950
All charts use the last traded price or closing price.

COMPANY PROFILE

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 6,282,510,461 (as at 30 Apr 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Pharmaceuticals Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 28 Oct 2016
Financial Year Ends 31 Dec 2024
Chairman Bai Xiaosong
Principal Office 41/F, China Resources Building
26 Harbour Road
Wanchai
Hong Kong
Place of Incorporation Hong Kong
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 18 May 2025 08:03 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
26 Mar 202528 May 2025Fin Div RMB 0.052
(HKD 0.056)
(with HKD, or
combination of these currencies option)
31 Dec 202430 May 2025 - 02 Jun 202514 Jul 2025
29 Aug 202410 Sep 2024Int (Semi-annual)
Div RMB 0.083
(HKD 0.0908)
(with HKD, or
combination of these currencies option)
31 Dec 202412 Sep 2024 - 13 Sep 202430 Oct 2024
26 Mar 202404 Jun 2024Fin Div RMB 0.154
(HKD 0.1697)
(with HKD, or
combination of these currencies option)
31 Dec 202306 Jun 2024 - 07 Jun 202419 Jul 2024
31 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
30 Mar 202305 Jun 2023Fin Div HKD 0.16
(RMB 0.14)
(with RMB, or
combination of these currencies option)
31 Dec 202207 Jun 2023 - 08 Jun 202321 Jul 2023
LOAD MORE
Updated: 17 May 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews